BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5385364)

  • 1. [Liver parenchyma damage by treatment with desferrioxamine B].
    Schmidt UJ; Kranz D; Brüschke G; Kalbe I; Rürup B
    Dtsch Gesundheitsw; 1969 May; 24(21):995-6. PubMed ID: 5385364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum transaminases and mental manifestations in alcoholic liver disease].
    Olivieri G; Tinelli G; Mancuso CE
    Fracastoro; 1971; 64(3):176-8. PubMed ID: 5143151
    [No Abstract]   [Full Text] [Related]  

  • 3. Alanine aminotransferase (GPT) in rainbow trout: plasma enzyme levels as an index of liver damage.
    Pfeifer KF; Weber LJ; Larson RE
    Proc West Pharmacol Soc; 1977; 20():431-7. PubMed ID: 896851
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate.
    Raab WP
    Arzneimittelforschung; 1971 Oct; 21(10):1620-1. PubMed ID: 5171899
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of somatostatin on galactosamine-induced liver injury.
    Limberg B; Kommerell B
    Klin Wochenschr; 1986; 64 Suppl 7():64-5. PubMed ID: 2882052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of some liver function tests routinely performed in early detection of damage to liver parenchyma in patients with pulmonary tuberculosis].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1205-9. PubMed ID: 5139239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of some parameters of liver damage under the influence of carbon tetrachloride, allyl alcohol and noradrenaline].
    Strubelt O; Siegers CP; Breining H
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):461-2. PubMed ID: 4253879
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-associated asymptomatic elevations of transaminase in drug safety assessments.
    Jick H
    Pharmacotherapy; 1995; 15(1):23-5. PubMed ID: 7739941
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stimulation and depression of toxicity of chloroform for the liver by drugs].
    Scholler KL; Müller E; von Plehwe U
    Arzneimittelforschung; 1970 Feb; 20(2):289-92. PubMed ID: 5467478
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver injury after contrast-enhanced, computed tomography with iopromide.
    Re G; Lanzarini C; Melandri R
    J Toxicol Clin Toxicol; 1998; 36(3):261-2. PubMed ID: 9656987
    [No Abstract]   [Full Text] [Related]  

  • 11. [The SGOT and SGPT levels in the recovery phase of acute lesions of the liver parenchyma].
    Schalm L
    Ned Tijdschr Geneeskd; 1969 Mar; 113(10):427-8. PubMed ID: 5767939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzyme diagnosis and liver diseases].
    Schmidt E; Schmidt FW
    Schweiz Med Wochenschr; 1969 Apr; 99(15):514-21. PubMed ID: 5784493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Damage to the liver parenchyma induced by desferrioxamine B therapy].
    Schmidt UJ; Brüschke G; Kranz D; Haase J; Ihle R
    Dtsch Gesundheitsw; 1968 Aug; 23(33):1542-4. PubMed ID: 5685936
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reaction of the damaged liver in experimental choledochus occlusion].
    Vido J; Vido I; Moravec R
    Acta Hepatosplenol; 1966; 13(4):228-32. PubMed ID: 5987793
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatotoxicity induced by anesthetics].
    Martínez Hernández A
    Rev Esp Enferm Apar Dig; 1976 Jun; 47(6):785-94. PubMed ID: 948692
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring patients taking methotrexate.
    Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1995 Apr; 32(4):680. PubMed ID: 7896967
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of vitamin B 6 deficiency on the behavior of serum transaminases (GOT, GPT) in clinical and experimental liver diseases].
    Gäng V; Gunzer U; Dragoun GP
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():524-7. PubMed ID: 612023
    [No Abstract]   [Full Text] [Related]  

  • 19. Transaminases in liver disease.
    Critz JB
    Med Times; 1968 Mar; 96(3):268-73. PubMed ID: 5639496
    [No Abstract]   [Full Text] [Related]  

  • 20. On the problem concerning the adaptation of the organism to repeated administration of a toxic agent in experiment.
    Vido I; Vido J
    Acta Hepatosplenol; 1965; 12(6):328-36. PubMed ID: 5868475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.